Syntis Bio (Series A)
Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
July 6, 2025
Vertical
Biopharmaceuticals
Funding URL
View Funding Page
Funding Amount
$33,000,000
Company Info
Organizations Involved
National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
Market
Healthcare
Location
Boston, MA, USA
Coinvestors
Mansueto Investments, Woori Venture Partners, Apollo Labs, BOLD Capital Partners, W. R. Berkley Corporation, Safar Partners, Portal Innovations, Colorcon Ventures, Cerity Partners Ventures
Company Description

Syntis Bio is a clinical-stage biopharmaceutical company developing oral therapies that harness the small intestine's unique biology to provide more accessible, effective and sustainable solutions across the healthcare spectrum, from rare genetic disorders to the world's most prevalent conditions.

Links
Website
Back to HomeBack to Biopharmaceuticals DealsView Funding Announcement